Virology Journal最新文献

{"title":"An outbreak of atypical hand, foot and mouth disease associated Coxsackievirus A6 in children from Cape Verde, 2023.","authors":"Ndack Ndiaye, Domingos Dias Teixeira, NDongo Dia, Carolina Cardoso Da Silva Leite, Gamou Fall, Ulardina Domingos Furtado, Yakhya Dieye, Mitsa Sanches, Ousmane Kébé, Fatou Diène Thiaw, Amadou Alpha Sall, Ousmane Faye, Boubacar Diallo, Abdourahmane Sow, Martin Faye","doi":"10.1186/s12985-025-02621-0","DOIUrl":"10.1186/s12985-025-02621-0","url":null,"abstract":"<p><strong>Background: </strong>Rash is a common childhood infection, mainly caused by viruses. Hand, foot, and mouth disease (HFMD), a common viral rash infection, has become one of the most common infectious diseases in Asian countries and caused outbreaks in children and adults worldwide. Following the introduction of enterovirus A71 (EVA71) vaccines, Coxsackievirus A6 (CVA6) has recently emerged. However, the disease is not commonly reported in Africa, where studies are scarce.</p><p><strong>Methods: </strong>In the current study, we focused on the HFMD outbreak that occurred in Cape Verde in July 2023 during field investigations around a cluster of patients with rash and fever. Samples collected from patients were tested using Measles and Rubella-specific immunoglobulin M and quantitative reverse transcription PCR (qRT-PCR) of a panel of viruses causing rashes and subjected to genome sequencing followed by phylogenetic analysis.</p><p><strong>Results: </strong>Eighteen out of the 22 samples were tested positive for CVA6 RNA by real-time RT-PCR, of which two tested also positive for EVA71 and Coxsackievirus A16 (CVA16). Subsequent sequencing revealed that all CVA6 sequences belonged to the D genotype, particularly the D3 sub-genotype recently described in China.</p><p><strong>Conclusion: </strong>Our study uncovers the first-ever reported outbreak of CVA6 associated with atypical HFMD in children from Cape Verde and highlights thus the need to implement an active hospital-based HFMD surveillance in Africa.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"48"},"PeriodicalIF":4.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11853985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143492539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of attenuated Orf virus as a safe oncolytic viral vector for nasopharyngeal carcinoma treatment.","authors":"Yumiko Yamada, Yu-Chih Wang, Hao-Ping Liu, Greg Ryan Gerongano, Ching-Yu Tseng, Shu-Chen Liu, Guan-Ru Liao, Chao-Chin Chang, Jiunn-Wang Liao, Mei-Lin Wang, Yuan-Yen Chang, Fong-Yuan Lin, Wei-Li Hsu","doi":"10.1186/s12985-025-02672-3","DOIUrl":"10.1186/s12985-025-02672-3","url":null,"abstract":"<p><strong>Background: </strong>Orf virus (ORFV) is gaining attention as a promising viral vector for cancer therapy because of its unique properties. Recent studies have shown that ORFV could be effective against various cancers, particularly nasopharyngeal carcinoma. This research explores the ability of wild-type ORFV and recombinant ORFVs, which lack specific virulence factors, to kill NPC cells and modulate the immune response.</p><p><strong>Methods: </strong>Two NPC cell lines, HK1 (from Hong Kong) and TW02 (from Taiwan), were infected with wild-type ORFV and two recombinant ORFVs lacking either vascular endothelial growth factor (VEGF) or chemokine binding protein (CBP) virulence factors. The oncolytic effects were evaluated by assessing cell death pathways, particularly pyroptosis, which was monitored through the cleavage of gasdermin E (GSDME). The activation of survival pathways, such as focal adhesion kinase (FAK) and AKT, was also analyzed. In addition, the influence of ORFV infection on natural killer (NK) cell recruitment and cytotoxicity was investigated. In vivo experiments were conducted in a xenograft mouse model in which HK1 tumors were used to evaluate the antitumor activity of wild-type ORFV and two deletion-mutant ORFVs.</p><p><strong>Results: </strong>Wild-type ORFV effectively killed NPC cells, especially HK1 cells. The recombinant ORFVs, despite being attenuated by the loss of VEGF or CBP, retained the ability to infect and cause NPC cell death, with the CBP-deleted virus showing notable effectiveness in HK1 cells. Early ORFV infection led to pyroptosis via GSDME cleavage, causing cell detachment and a reduction in FAK and AKT activation. ORFV also enhanced NK cell recruitment and boosted NK cell-mediated cytotoxicity in infected NPC cells. In the HK1 xenograft model, CBP-deleted ORFV significantly inhibited tumor growth.</p><p><strong>Conclusion: </strong>ORFV, particularly the wild-type and CBP-deleted variants, has significant potential as an oncolytic viral vector for NPC therapy. It induces cell death via pyroptosis and enhances immune-mediated tumor cell destruction through NK cells. The attenuated CBP-deleted ORFV offers a safer and effective option for cancer treatment, making it a promising candidate for future therapeutic applications.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"50"},"PeriodicalIF":4.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11863438/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143504371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"NIEAs elicited by wild-type SARS-CoV-2 primary infection fail to enhance the infectivity of Omicron variants.","authors":"Qi Gui, Haiyan Wang, Congcong Liu, Wenting Li, Bing Zhou, Shilong Tang, Qing Fan, Xiangyang Ge, Bin Ju, Zheng Zhang","doi":"10.1186/s12985-025-02667-0","DOIUrl":"10.1186/s12985-025-02667-0","url":null,"abstract":"<p><p>SARS-CoV-2 infection widely induces antibody response targeting diverse viral proteins, including typical representative N-terminal domain (NTD), receptor-binding domain (RBD), and S2 subunit of spike. A lot of NTD-, RBD-, and S2-specific monoclonal antibodies (mAbs) have been isolated from COVID-19 convalescents, some of which displaying potent activities to inhibit viral infection. However, a small portion of NTD-specific mAbs elicited by wild-type (WT) SARS-CoV-2 primary infection could facilitate the virus entry into target cells in vitro, so called NTD-targeting infection-enhancing antibodies (NIEAs). To date, SARS-CoV-2 has evolved to massive variants carrying various NTD mutations, especially recent Omicron BA.2.86 and JN.1. In this study, we investigated whether these WT-NIEAs could still enhance the infectivity of emerging Omicron variants. Nine novel WT-NIEAs with diverse germline gene usage were identified from 3 individuals, effectively enlarging available antibody panel of NIEAs. Bivalent binding of NIEAs to inter-spike contributed to their infection-enhancing activities. WT-NIEAs could enhance the infectivity of SARS-CoV-2 variants emerged before Omicron, but ineffective to Omicron variants including BA.2.86 and JN.1, which was because of their changed antigenicity of NTDs. Overall, these data clearly demonstrated the cross-reactivity of these pre-existed WT-NIEAs to a series of SARS-CoV-2 variants, helping to evaluate the risk of enhanced infection of emerging variants in future.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"45"},"PeriodicalIF":4.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11849304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143493361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Activating transcription factor 3 induces oxidative stress and genotoxicity, transcriptionally modulating metastasis-related gene expression in human papillomavirus-infected cervical cancer.","authors":"Elham Naderzadeh, Mohammad Kargar, Mohammad Javad Mokhtari, Ali Farhadi","doi":"10.1186/s12985-025-02675-0","DOIUrl":"10.1186/s12985-025-02675-0","url":null,"abstract":"<p><strong>Background: </strong>Activating Transcription Factor 3 (ATF3) is known for its tumor-suppressive properties in cervical cancer, particularly through its role in stress response and interactions with human papillomavirus (HPV) oncogenes. This study investigates ATF3's regulatory impact on metastasis-related genes, oxidative stress, and DNA damage in HPV-positive cervical cancer cells.</p><p><strong>Methods: </strong>HeLa and Ca Ski cell lines were transfected with ATF3-expressing vectors. Western blotting and quantitative reverse transcription polymerase chain reaction (RT-qPCR) were used to confirm ATF3 overexpression following transfection. ROS assays and Comet assays assessed the impact of ATF3 on oxidative stress and DNA damage, while RT-qPCR was used to evaluate changes in HPV E6/E7, SHARP1, and MMP1 gene expression.</p><p><strong>Results: </strong>ATF3 overexpression led to elevated ROS levels (p < 0.02), resulting in oxidative DNA damage. These results demonstrate ATF3's cytotoxic impact on cervical cancer cells through oxidative stress and DNA damage. Additionally, ATF3 overexpression significantly decreased MMP1 expression (p < 0.03), indicating a potential anti-metastatic effect, while SHARP1 and HPV E6/E7 expression levels were not significantly altered, indicating selective gene modulation by ATF3.</p><p><strong>Conclusion: </strong>These findings reveal that ATF3 contributes to tumor suppression in cervical cancer by modulating oxidative stress and DNA damage, selectively targeting genes involved in metastasis. These findings supports ATF3's role in regulating key pathways in HPV-positive cervical cancer cells, providing a basis for further exploration of ATF3 as a target in therapeutic strategies aimed at improving outcomes in cervical cancer.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"46"},"PeriodicalIF":4.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11849226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143493899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic assessment of cervical cancer based on biomarkers: the interaction of ERRα and immune microenvironment.","authors":"Meijin Zheng, Weifeng Huang, Dingjie Wang, Leyi Huang, Yuan Ren, Qiao Gao, Yuxuan Huang, Wenyu Lin, Lihua Chen","doi":"10.1186/s12985-025-02664-3","DOIUrl":"10.1186/s12985-025-02664-3","url":null,"abstract":"<p><strong>Background: </strong>Cervical cancer poses a substantial global health challenge. Estrogen-related receptor alpha (ERRα) is a central regulator of cellular energy metabolism associated with poor cancer prognosis. However, the effect of ERRα expression on cervical cancer prognosis and immune infiltration has not been explored. This study aims to clarify the expression pattern and role of ERRα in cervical cancer.</p><p><strong>Methods: </strong>We analyzed ERRα expression and its clinical prognosis in cervical cancer using multiple databases, including The Cancer Genome Atlas (TCGA) and Tumor Immune Estimation Resource (TIMER). The results were further validated through immunohistochemistry (IHC) on 221 cervical cancer tissue samples. Furthermore, Kaplan-Meier and Cox regression analyses were used to assess the clinical significance of ERRα in cervical cancer patients. All calculations were performed using the R package.</p><p><strong>Results: </strong>ERRα expression was significantly higher in cervical cancer tissues compared to normal tissues. High ERRα expression was associated with poor overall survival (OS), disease-specific survival (DSS), and progression-free survival (PFS). Multivariate Cox regression analysis confirmed ERRα as an independent prognostic factor. Additionally, ERRα expression correlated with various immune cell types and immune checkpoints, indicating its role in the tumor immune microenvironment.</p><p><strong>Conclusions: </strong>ERRα emerges as a promising prognostic biomarker in cervical cancer, influencing immune cell infiltration and potentially guiding personalized therapeutic approaches. Future investigations are warranted to delineate the mechanistic pathways through which ERRα contributes to cervical cancer progression and to assess its viability as a target for innovative immunotherapy strategies.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"47"},"PeriodicalIF":4.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11852515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143493481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical symptoms and molecular epidemiologic characteristics of varicella patients among children and adults in Ganzhou, China.","authors":"Ting Zeng, Chao-Xian Lian, Xiao-Yi Zhang, Ping-Qing Liu, Jian Ao, Gang-Feng Zhou, Xiao-Dong Chen, Dan-Dan Huang, Dian-Gui Hu, Xin Chen","doi":"10.1186/s12985-025-02661-6","DOIUrl":"10.1186/s12985-025-02661-6","url":null,"abstract":"<p><strong>Background: </strong>Varicella-zoster virus (VZV) is highly transmissible; however, there are limited studies in China.</p><p><strong>Methods: </strong>The clinical symptoms, disease progression, and laboratory test results of varicella patients among children and adults diagnosed at Ganzhou Fifth People's Hospital from August 2021 to December 2022 were analysed retrospectively. Genetic polymorphisms in the open reading frame (ORF) 22 and ORF62 fragments of VZV isolates were analysed using molecular epidemiological methods.</p><p><strong>Results: </strong>Thirty-nine varicella patients were included in this study, 26 of them were children and 13 of them were adults. The incidence of discomfort and complications was significantly greater in adults than in children (P < 0.05). Four adults developed severe disease, one of whom died, with no cases of severe disease or death among children. The 32 VZV clinical isolates were all Clade 2 wild-type strains. Four variant isolates from children had eight base mutations, five of which were missense; two variant isolates from adults had four base mutations, all of which were missense.</p><p><strong>Conclusions: </strong>The risk of developing severe disease or even death after VZV infection in adults was greater than that in children. There is an urgent need for more studies focusing on the differences in the pathogenicity of VZV in different age groups.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"44"},"PeriodicalIF":4.0,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11844084/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143477022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the link between parvovirus B19 and encephalitis: a systematic review and comprehensive meta-analysis of molecular and serological evidence.","authors":"Kashmi Sharma, Rekha Khandia, Rohan Shrivastava, Ram K Nema, Somesh Mishra, Rupinder K Kanwar, Ashwin A Raut, Amit Agrawal, Vandana Gupta, Megha K Pandey","doi":"10.1186/s12985-025-02630-z","DOIUrl":"10.1186/s12985-025-02630-z","url":null,"abstract":"<p><p>Encephalitis, a severe brain inflammation, can arise due to various infectious agents, including viruses like Parvovirus B19 (B19V). Previously linked to mild neonatal and young one's illnesses and some haematological diseases, recent evidence associates B19V with encephalitis, with no clear prevalence and mechanisms in place. This systematic review and meta-analysis aim to determine the prevalence of B19V in cases of encephalitis, exploring variations associated with diagnostic approaches, and identifying gaps in existing research to enhance clinical comprehension and diagnostic methods. An extensive search (1994-2024) was performed through PubMed, Scopus, ScienceDirect, and Cochrane databases for research and epidemiological investigations related to B19V in cases of encephalitis. Inclusion criteria focused on studies that verified B19V using molecular (PCR, NGS) or serological (IgM/IgG) techniques in cerebrospinal fluid or serum. Data analysis was done to pool the prevalence data of included studies using a random-effects model. Heterogeneity was evaluated using I² statistics. Sensitivity and meta-regression analyses were conducted to evaluate variability and the effects of moderators. A total of fourteen studies involving 3,135 encephalitis patients resulted in a combined prevalence of 3% (95% CI: 2-4%). Studies using PCR indicated a greater prevalence (3%) in comparison to ELISA (1%) and NGS (2%). A moderate level of heterogeneity (I² = 57.4%) was attributed to the variability in diagnostic methods and geographic distribution. Sensitivity analyses validated strong estimates, while meta-regression revealed country as a key moderator accounting for heterogeneity. Publication bias was modest. The research indicates that B19V may be involved in certain encephalitis instances, with an overall prevalence of 3%. The differences observed in the studies emphasize the need for standardized diagnostic procedures and more extensive multicentric epidemiological research.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"42"},"PeriodicalIF":4.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11837615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detection of SARS-CoV-2 in nasopharyngeal swab samples from COVID-19 patients in Riyadh, Saudi Arabia: a PCR-based study.","authors":"Rania Ali El Hadi Mohamed, Shikha Fahad Alojayan, Albandary Nasser Alsaloom, Sheka Yagub Aloyouni, Khawlah Aldilaijan, Sarah Abdullah Ababtain","doi":"10.1186/s12985-025-02655-4","DOIUrl":"10.1186/s12985-025-02655-4","url":null,"abstract":"<p><p>This study involved laboratory experiments using conventional PCR to detect the RNA-dependent RNA polymerase protein (RdRp) and Envelope (E) genes in Forty-Seven nasopharyngeal swab samples from COVID-19 patients in Riyadh, Saudi Arabia. Gel electrophoresis results showed amplification of the RdRp gene in 85.1% of the samples and the E gene in 89.4%, confirming the widespread presence of these viral genes. The presence of bands in positive controls indicated the specificity of the primers whilst no bands were detected in the negative controls, indicating the absence of contamination. The study also included data collection from databases to explore the demographic and clinical characteristics of COVID-19 patients. The male to female infection ratio was 363:63, significantly favoring males (P ≤ 0.05). Fever was present in 81.46% of patients (P ≤ 0.05). A significant portion (60.56%) had not contacted positive cases or traveled outside Saudi Arabia (P ≤ 0.05). The Saudi to non-Saudi ratio among patients was 24.65-75.35% (P ≤ 0.05). Age distribution showed 62.21% of patients were under 50 years old (P ≤ 0.05). ICU admission was required for 12.21% of patients (P ≤ 0.05). Co-morbidities were present in 27.46% of patients (P ≤ 0.05). The mortality rate was low, with a deceased to alive ratio of 1:141 (P ≤ 0.05). Gel electrophoresis revealed that 85.1% of samples showed amplification for the RdRp gene, and 89.4% for the E gene, confirming the widespread presence of these viral genes among the samples tested.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"43"},"PeriodicalIF":4.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11837285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Genotypic analysis of human papillomavirus in cervical exfoliated cells from women in Zigong.","authors":"Xiaoyang Ma, Chuan Wu, Tao Wu, Xiaolin Yu, Lixing Song","doi":"10.1186/s12985-025-02652-7","DOIUrl":"10.1186/s12985-025-02652-7","url":null,"abstract":"<p><strong>Background: </strong>This study investigated the human papillomavirus (HPV) infection status among women in Zigong from January 2016 to August 2024 and provides a comprehensive statistical analysis of HPV infection characteristics. The findings aim to enhance cervical cancer screening, inform vaccination strategies, and improve HPV infection prevention measures.</p><p><strong>Methods: </strong>We conducted a retrospective analysis on 48,474 female patients who visited the gynecology department of Zigong Fourth People's Hospital from January 2016 to August 2024. Cervical exfoliated cell samples were collected from the patients, and the genotypes of 10 low-risk HPV (LR-HPV) and 17 high-risk HPV (HR-HPV) were detected by flow fluorescent hybridization technique. The study explored HPV infection rates, genotype distribution, number of infections, type of infections, and age distribution. The chi-squared (χ²) test was employed to compare infection statuses between groups.</p><p><strong>Results: </strong>Among the 48,474 patients, 9749 tested positive for HPV, with an overall infection rate of 20.11%. The HPV infection rate increased gradually from 2016 to 2024 (P < 0.001). The infection rates of single, double, triple, and ≥ quadruple infections were 15.11%, 3.54%, 1.00%, and 0.46%, respectively. The infection rates were 4.41% for LR-HPV-only, 13.13% for HR-HPV-only, and 2.57% for mixed LR and HR-HPV. HR-HPV primarily consisted of HPV types 52, 16, 53, and 58, with infection rates of 3.94%, 2.71%, 2.43%, and 2.42%, respectively. LR-HPV primarily consisted of types 61 and 81, with infection rates of 1.64% and 1.49%, respectively. A significant age correlation in HPV infection was observed (P < 0.001), with two distinct peaks in infection rates.</p><p><strong>Conclusions: </strong>The HPV infection rate among women visiting the gynecology department in Zigong is high, predominantly involving HPV types 52, 16, 53, and 58. Therefore, strengthening HPV screening efforts and focusing on standardized genotype screening is crucial. Additionally, selecting HPV vaccines targeting prevalent genotypes and actively conducting HPV prevention and control work can reduce the incidence of HPV-related cervical cancer and other HPV-related diseases.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"40"},"PeriodicalIF":4.0,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term inhibition of Hepatitis B virus gene expression by a primary microrna expressing ancestral adeno-associated viral vector.","authors":"Njabulo Ziphezinhle Mnyandu, Shonisani Wendy Limani, Abdullah Ely, Reubina Wadee, Patrick Arbuthnot, Mohube Betty Maepa","doi":"10.1186/s12985-025-02662-5","DOIUrl":"10.1186/s12985-025-02662-5","url":null,"abstract":"<p><p>Current treatments for chronic infection with the hepatitis B virus (HBV) rarely cure carriers from the disease. Previously reported use of serotype 8 adeno-associated viral (AAV8) vectors to deliver expression cassettes encoding anti-HBV artificial primary microRNAs (apri-miRs) has shown promise in preclinical studies. A recently designed synthetic ancestral AAV (Anc80L65) with high liver transduction efficiency is a promising new addition to the anti-HBV vector toolbox. This study engineered Anc80L65 to express HBx-targeting apri-miRs. Single dose administration of the vectors to cultured cells and HBV transgenic mice effected reductions of secreted HBV surface antigen (HBsAg). Circulating HBV particles and HBV core antigen (HBcAg) were also significantly diminished in mice receiving the anti-HBV apri-miR-expressing ancestral AAVs. Downregulation of HBV biomarkers occurred over a period of 12 months. Absence of inflammatory responses or liver toxicity indicated that the vectors had a good safety profile. These data suggest that a single dose of apri-miR-expressing Anc80L65 is safe and capable of mediating durable suppression of HBV gene expression. Targeting HBx, which is required for transcriptional activity of covalently closed circular DNA of HBV, makes this Anc80L65-derived vector a promising candidate for functional cure from chronic HBV infection.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"41"},"PeriodicalIF":4.0,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}